Genetic reduction of lipoic acid synthase expression modestly increases atherosclerosis in male, but not in female, apolipoprotein E-deficient mice

Atherosclerosis

Volumn 211, Issue 2, 2010, Pages 424-430

  Yi, Xianwen ^a   Xu, Longquan ^a   Kim, Kuikwon ^a   Kim, Hyung Suk ^a   Maeda, Nobuyo ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Antioxidant; Apolipoprotein E null mice; Atherosclerosis; Lias mouse model; Lipoic acid

Indexed keywords

APOLIPOPROTEIN E; COPPER ZINC SUPEROXIDE DISMUTASE; GLUTATHIONE; MANGANESE SUPEROXIDE DISMUTASE; PYRUVATE DEHYDROGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; AORTA SINUS; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; GENE; GENE EXPRESSION; LIPOIC ACID SYNTHASE GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENCE;

ANIMALS; ANTIOXIDANTS; AORTA; APOLIPOPROTEINS E; ATHEROSCLEROSIS; ERYTHROCYTES; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HETEROZYGOTE; LIVER; MALE; MICE; MICE, KNOCKOUT; SEX FACTORS; SULFURTRANSFERASES;

EID: 77955266660     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.03.009     Document Type: Article

References (25)

1. Steinberg D., Witztum J.L. Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis. Circulation 2002, 105(17):2107-2111.
2. Biewenga G.P., Haenen G.R., Bast A. The pharmacology of the antioxidant lipoic acid. Gen Pharmacol 1997, 29:315-331.
3. Reed L.J. From lipoic acid to multi-enzyme complexes. Protein Sci 1998, 7:220-224.
4. Zhang W.J., Bird K.E., McMillen T.S., et al. Dietary alpha-lipoic acid supplementation inhibits atherosclerotic lesion development in apolipoprotein E-deficient and apolipoprotein E/low-density lipoprotein receptor-deficient mice. Circulation 2008, 117:421-428.
5. Amom Z., Zakaria Z., Mohamed J., et al. Lipid lowering effect of antioxidant alpha-lipoic Acid in experimental atherosclerosis. J Clin Biochem Nutr 2008, 43:88-94.
6. Zulkhairi A., Zaiton Z., Jamaluddin M., et al. Alpha lipoic acid possess dual antioxidant and lipid lowering properties in atherosclerotic-induced New Zealand White rabbit. Biomed Pharmacother 2008, 62:716-722.
7. Çakatay U., Kayali R., Sivas A., Tekeli F. Prooxidant activities of α-lipoic acid on oxidative protein damage in the aging rat heart muscle. Arch Gerontol Geriatr 2005, 40:231-240.
8. Shih J.C. Atherosclerosis in Japanese quail and the effect of lipoic acid. Fed Proc 1983, 42:2494-2497.
9. Yi X., Maeda N. Alpha-lipoic acid prevents the increase in atherosclerosis induced by diabetes in apolipoprotein E-deficient mice fed high-fat/low-cholesterol diet. Diabetes 2006, 55:2238-2244.
10. Angelucci L., Mascitelli-Coriandoli E. Anticholesterol activity of alpha-lipoic acid. Nature 1958, 181:911-912.
11. Yi X., Maeda N. Endogenous production of lipoic acid is essential for mouse development. Mol Cell Biol 2005, 25:8387-8392.
12. Yi X., Kim K., Yuan W., et al. Mice with heterozygous deficiency of lipoic acid synthase have an increased sensitivity to lipopolysaccharide-induced tissue injury. J. Leukoc Biol 2009, 85(1):146-153.
13. Maeda N., Johnson L., Kim S., et al. Anatomical differences and atherosclerosis in apolipoprotein E-deficient mice with 129/SvEv and C57BL/6 genetic backgrounds. Atherosclerosis 2007, 195(1):75-82.
14. Zhang S.H., Reddick R.L., Burkey B., Maeda N. Diet-induced atherosclerosis in mice heterozygous and homozygous for apolipoprotein E gene disruption. J Clin Invest 1994, 94:937-945.
15. Valero E., Garcia-Carmona F. Optimizing enzymatic cycling assays: spectrophotometric determination of low levels of pyruvate and l-lactate. Anal Biochem 1996, 239:47-52.
16. Yi X., Maeda N. Alpha-lipoic acid prevents the increase in atherosclerosis induced by diabetes in apolipoprotein E-deficient mice fed high-fat/low-cholesterol diet. Diabetes 2006, 55(8):2238-2244.
17. Schummer C.M., Werner U., Tennagels N., et al. Dysregulated pyruvate dehydrogenase complex in Zucker diabetic fatty rats. Am J Physiol Endocrinol Metab 2008, 294:E88-96.
18. Ohara Y., Peterson T.E., Harrison D.G. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 1993, 91:2546-2551.
19. Packer L., Witt E.H., Tritschler H.J. Alpha-lipoic acid as a biological antioxidant. Free Radic Biol Med 1995, 19:227-250.
20. t Hoen P.A., Van der Lans C.A., Van Eck M., et al. Aorta of ApoE-deficient mice responds to atherogenic stimuli by a prelesional increase and subsequent decrease in the expression of antioxidant enzymes. Circ Res 2003, 93:262-269.
21. Steinberg D. Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime. Nat Med 2002, 8:1211-1217.
22. Kim M.S., Park J.Y., Namkoong C., et al. Anti-obesity effects of alpha-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase. Nat Med 2004, 10:727-733.
23. Martin E., Rosenthal R.E., Fiskum G. Pyruvate dehydrogenase complex: metabolic link to ischemic brain injury and target of oxidative stress. J Neurosci Res 2005, 79:240-247.
24. Raghavamenon A., Garelnabi M., Babu S., et al. Alpha-tocopherol is ineffective in preventing the decomposition of preformed lipid peroxides and may promote the accumulation of toxic aldehydes: a potential explanation for the failure of antioxidants to affect human atherosclerosis. Antioxid Redox Signal 2009, 11(6):1237-1248.
25. Miller A.A., De Silva T.M., Jackman K.A., Sobey C.G. Effect of gender and sex hormones on vascular oxidative stress. Clin Exp Pharmacol Physiol 2007, 34:1037-1043.